Centro Médico Teknon
The doctor is an M.D., Ph.D., Ophthalmologist specializing in macula and vitreorretinal conditions. Known for significant contributions to ophthalmology, the doctor has advanced macular degeneration imaging techniques and treatment protocols. With a focus on pathophysiology, imaging, and emerging therapies for AMD and retinal degenerative diseases, the doctor has completed specialized training in ophthalmology at the Universitat Autònoma de Barcelona and fellowships at Harvard University and the Instituto Tecnológico y de Estudios Superiores de Monterrey.
The doctor is a Research Member Elect of the International Alliance AMD and a scientific adviser to the European Association for Vision and Eye Research. Memberships include 12 scientific societies such as the Macula Society and The Retina Society.
The doctor has focused research on paraneoplastic neurological syndromes, leading a panel that established diagnostic criteria. His work confirmed the immune hypothesis linking tumors to autoimmune neurological dysfunctions, with antibodies identified by him now essential for diagnosis.
Clinically, the doctor specializes in diagnosing and managing gliomas, primary brain lymphomas, and cancer treatment-related neurotoxicities. Recent interests include neurological complications from immune checkpoint inhibitors and hematopoietic stem cell transplantation.
He holds an MD and PhD from Universitat Autónoma de Barcelona, completed a neurology residency in Barcelona, and a neuro-oncology fellowship at Memorial Sloan-Kettering Cancer Center.
The doctor is a highly skilled neurosurgeon specializing in the treatment of brain tumors. With extensive experience in both surgical and non-surgical approaches, the doctor has contributed significantly to advancements in neuro-oncology. The doctor is recognized for implementing cutting-edge techniques and has published numerous research papers in leading medical journals. The doctor is committed to improving patient outcomes through innovative treatment strategies and is actively involved in clinical trials aimed at developing new therapies for brain tumor patients.